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Abstract 34 
Background: The quality of asthma primary care may vary between countries, health care practices, and 35 
health care professionals (HCPs). Identifying and explaining such differences is critical for health services 36 
improvement. 37 
Objectives: To examine the quality of asthma primary care in France and United Kingdom, and identify 38 
within-country and between-country predictors amenable to intervention. 39 
Methods: An online questionnaire to capture asthma medical care and self-management support, practice 40 
characteristics, and psychosocial determinants, was completed by 276 HCPs. Mokken Scaling analyses 41 
were used to examine item structure and consistency. Hierarchical regression analyses were used to 42 
identify predictors of the amount (number of asthma care activities HCPs delivered) and consistency (the 43 
degree to which HCPs deliver similar care) of asthma medical care and self-management support. 44 
Results: On average, HCPs reported delivering 74,2% of guideline-recommended care. Consistency of 45 
medical care and self-management support was lower among HCPs delivering a lower amount of care 46 
(r=.58 and r=.57, p<.001). UK HCPs provided more and more consistent asthma self-management 47 
support –but not medical care- than French HCPs, which was explained by the presence of practice 48 
nurses in the UK. More training, positive social norms, and higher behavioural control explained better 49 
quality of care across all HCPs. 50 
Conclusions: Using carefully-developed questionnaires and advanced psychometric analyses, this study 51 
suggests that involving practice nurses, making social expectations visible, and providing more training to 52 
enhance skills and confidence in asthma care delivery could enhance the amount and consistency of 53 
asthma primary care. This needs to be corroborated in a future intervention trial. 54 
 55 
Keywords: asthma; quality of care; adherence; self-management; primary care; implementation; 56 
guidelines 57 
Abbreviations: Health Care Providers (HCPs), United Kingdom (UK), Theory of Planned Behaviour (TPB), 58 
Mokken Scaling Analyses (MSA), Quality Outcomes Framework (QOF) 59 
60 
  
Highlights 61 
 62 
1. What is already known about this topic? 63 
 64 
Previous research suggests that there may be variation in the content of asthma care delivered in primary 65 
care, between and within-countries. 66 
 67 
2. What does this article add to our knowledge? 68 
 69 
This study reveals that the amount and consistency of asthma care varies substantially between primary 70 
care providers in the UK and France, and identifies important modifiable predictors of suboptimal care 71 
delivery 72 
 73 
3. How does this study impact current management guidelines? 74 
 75 
Involving nurses in asthma care, making patient expectations visible, and providing more training to 76 
enhance skills and confidence in asthma care delivery, could imrpove the quality of asthma medical care 77 
and self-management support. 78 
  79 
  
BACKGROUND 80 
Asthma continues to represent a global public health problem, affecting more than 300 million 81 
people worldwide (1,2). Uncontrolled asthma remains prevalent, with high costs for individuals and 82 
society (3,4). To support patients in achieving and maintaining asthma control, asthma care guidelines 83 
recommend health care professionals (HCPs) in primary care to deliver medical and self-management 84 
support (5–7). For these guidelines to benefit patients, they need to be widely adopted (8). Studies 85 
suggest that asthma care delivery is suboptimal (9–19), but research on this topic is still incipient. Most 86 
available studies have focused on a limited set of guideline-recommended activities and measured 87 
guideline implementation indirectly (e.g., through HCP knowledge tests or vignettes with hypothetical 88 
scenarios). No prior investigation focused on how much (the amount) of the guideline-recommended 89 
activities were routinely delivered to patients, explored whether different HCPs deliver similar asthma care 90 
(the consistency of care), or identified factors that explain differences in the quality of asthma care 91 
provided. To progress, we need to examine both the amount and consistency of asthma care using a 92 
comprehensive set of questions that capture medical care and self-management support directly (i.e., 93 
measure HCP behaviour rather than guideline knowledge), and identify the main quality of care 94 
determinants that can be targeted in future service improvement interventions. 95 
Within a European Commission-funded asthma cohort study in the United Kingdom (UK) and 96 
France (20), we aimed to investigate the amount, consistency, and determinants of asthma care in 97 
primary care. The two different health care systems also provided an opportunity for between-country 98 
comparisons and reflecting on system-level influences on the quality of asthma care provided. Since 99 
2004, UK primary care is guided by a performance management framework called the Quality and 100 
Outcomes Framework (QOF), which includes performance pay for several guideline-recommended 101 
asthma care activities. Some studies suggest that QOF resulted in improved performance on incentivised 102 
indicators of quality of care (21,22). The French health care system is similar to the UK system as it 103 
provides universal cover through a combination of public and private hospital and ambulatory care (23), 104 
however historically it has been more focused on hospital-based and specialist care (24). A pay-for-105 
performance system to meet several prevention, prescription and chronic disease management goals 106 
was introduced in France in 2008, but with limited success (24). These system-level differences would be 107 
  
expected to result in differences in how asthma care is delivered in primary care. In particular, the 108 
expectation could be that asthma primary care in the UK is more comprehensive and consistent than in 109 
France. 110 
The current study examined and compared the amount and consistency of medical care and self-111 
management support provided to asthma patients in primary care in the UK and France, and aimed to 112 
identify determinants that can explain variations in care within and between countries.  113 
METHODS 114 
Study design and participants 115 
HCPs participating in patient recruitment for the ASTRO-LAB cohort in France and the UK (maximum 4 116 
HCPs per practice) were invited via email to complete an online survey on their asthma care practices. No 117 
additional selection criteria were used. Thus, the sample size was determined by the number of HCPs in 118 
the cohort willing to participate. The study design, including ethics approvals, is detailed elsewhere (20). 119 
Measures 120 
The survey included questions on routine provision of medical care and self-management support to 121 
patients with persistent asthma who were prescribed (at least) daily use of an inhaled corticosteroid (ICS). 122 
We also collected data on HCP and practice characteristics, including HCP psychosocial determinants of 123 
providing asthma care.  124 
Asthma care activities 125 
To identify core medical care and self-management support activities for asthma management in primary 126 
care, we reviewed the literature on asthma care measurement and recent guidelines (5–7). We identified 127 
two questionnaires (17,18, 19, 25). As self-management support, particularly medication adherence, was 128 
less detailed in these guidelines and tools, we adapted additional items from previous research assessing 129 
adherence support in routine clinical care in other conditions (26–28). The items identified were 130 
formulated in English and back-translated to French. Cognitive (‘think-aloud’) interviews with 6 HCPs in 131 
both countries were conducted to ensure relevance and comprehensibility. Following this process, we 132 
aimed to ensure a good coverage of asthma care activities relevant for achieving good clinical outcomes, 133 
which HCPs can relate to and report on with minimal response burden. 134 
  
The checklist included 12 medical and 25 self-management support activities. The item content 135 
and sources are detailed in the Online Repository (Table E1). In line with research suggesting that self-136 
reports of behaviour are more accurate amongst people performing a behaviour routinely (most or all of 137 
the time) (29), we asked HCPs whether during the last 12 months they performed that activity with the 138 
majority of their patients on daily preventer therapy. The response options were ‘Yes’, ‘No’, and ‘I don’t 139 
know’ (recoded to ‘No’ for analysis). Previous meta-analyses in another topic area (HIV care) 140 
demonstrated high reliability and strong predictive validity of this approach (26,27). To further increase 141 
validity and limit social desirability, the survey was anonymous and reassured respondents in an 142 
introductory statement that its purpose was not to verify HCP’s knowledge, but to understand their daily 143 
practice and personal perspectives. 144 
HCP and practice characteristics 145 
Additional survey questions measured practice characteristics, socio-demographics, and professional 146 
background. We also assessed psychosocial determinants of care delivery based on the Theory of 147 
Planned Behaviour (TPB), which has been extensively used to explain patient and HCP behaviours 148 
(30,31). TPB states that in order to perform a behaviour people need to value performance of the 149 
behaviour positively (attitude), perceive that other significant people perform or expect them to perform 150 
the behaviour (subjective norms), and feel confident in their ability to perform the behaviour (perceived 151 
behavioural control), and consequently have a strong intention to act accordingly (behavioural intention). 152 
To limit respondent burden, TPB questions were only formulated only for self-management support. We 153 
used a 7-point Likert response scale and included 24 attitude, subjective norm, and perceived 154 
behavioural control items (see Table 1 for example items). 155 
 156 
INSERT Table 1 ABOUT HERE 157 
 158 
Analysis 159 
Data analyses were conducted using R (32). Between-country differences were explored using Fisher’s 160 
exact tests for binary, Wilcoxon rank-sum tests for ordinal, and t-tests for continuous variables; 161 
comparisons referring to individual asthma care delivery activities were Holm-adjusted for multiple testing.  162 
  
 The amount of medical care and self-management support were computed as total number of care 163 
activities reported. To examine consistency of care at the country level, we first performed Moken Scaling 164 
Analyses (MSA; (33)) per country, using items with sufficient variability (i.e., endorsed by 5%-95% of 165 
HCPs). MSA is a non-parametric item response theory methodology commonly used to examine 166 
psychometric properties of item sets developed to measure unidimensional constructs and differing in 167 
levels of difficulty (frequencies of endorsement in a given sample). Items and scales are evaluated in 168 
terms of homogeneity, monotonicity, local independence, and invariant item ordering; items that meet 169 
these criteria are considered appropriate for calculating global scores which reflect differences between 170 
respondents on a latent ordinal construct (34). Scale dimensionality was tested against a homogeneity 171 
threshold of H=.30. An exploratory item selection algorithm (aisp) was performed at increasing 172 
homogeneity thresholds to identify unidimensional scales (35). Monotonicity and invariant ordering 173 
assumptions were examined to identify item subsets that reflect how consistent asthma care is in each 174 
country. Consistency of care at the individual HCP level was operationalized as number of Guttman 175 
errors (G estimates), a person-fit indicator in MSA that reflects how consistent individual HCP response 176 
patterns are with the sample-characteristic response pattern (higher scores reflect lower consistency) 177 
(36,37). 178 
To examine which factors explain the amount and consistency of care, four hierarchical regression 179 
analyses were conducted with asthma care sum scores (amount) and G estimates (consistency) of 180 
medical care and self-management support as dependent variables. The regression analyses included 3 181 
models: 1) country, 2) practice characteristics, 3) individual characteristics, including psychosocial 182 
determinants for self-management support only. To allow for the analysis of both the effect of country and 183 
of profession (i.e., in the UK, nurses – not only GPs – also deliver asthma care), a dummy variable 184 
distinguishing French GPs from UK HCPs was included in Model 1 (test for country differences), and 185 
Model 2 included a dummy variable for ‘UK nurse’ (to compare UK GPs, with UK nurses and French 186 
GPs). We ran the analyses including all predictors variables, and once using a more parsimonious model 187 
that included only practice and individual HCP characteristics that showed at least weak bivariate 188 
associations with the dependent variables (Pearson’s r p≤.10; correlations in Table E2). Results were 189 
essentially identical and the full models is reported here. 190 
  
The dataset used for these analyses can be found at osf.io/wk8vm. 191 
 192 
RESULTS 193 
Sample characteristics 194 
A total of 276 HCPs completed the survey between November 2013 and January 2016: 156 (56.5%, all 195 
GPs) in France and 120 (43.5%; 68 GPs and 52 practice nurses) in the UK. UK practices were larger, 196 
with 15.8% (UK) and 62.8% (France) working in a practice with 1-3 GPs, and 40.9% (UK) versus 0.6% 197 
(France) in practices with >6 GPs. Only UK practices also employed nurses (100%), health care 198 
assistants (67.5%), and pharmacists (24.2%). UK HCPs had consultations with asthma patients more 199 
often than French HCPs (85.8% versus 39.7% saw at least one asthma patient every week). French 200 
HCPs performed asthma review consultations every 3 months (57.7%) or 6 months (28.8%), which lasted 201 
15 (41.03%) or 20 (46.1%) minutes. UK HCPs saw patients less frequently (30.0% at 6 months and 202 
60.8% at 12 months), and consultations were shorter for GPs (88.3% had 10 minutes) and similar for 203 
nurses (26.7% had 15 and 54.2% 20 minutes). Except for 2 French HCPs, all respondents had peak flow 204 
meters available in the practice. UK practices were however better equipped than French GPs with 205 
spirometers (98.3% vs 24.4%), pulse oximeters (99.1% vs 59.6%), large volume spacers (93.3% vs 206 
78.2%), and nebulizers (98.3% vs 9.6%). Use of guidelines for asthma management was reported by 207 
66% of French HCPs (GINA, HAS, or SFP) versus 98.3% UK HCPs (NICE, BTS/SIGN, or local 208 
guidelines, e.g., from Clinical Commissioning Groups). Common socio-demographics and professional 209 
background characteristics are presented in Table 2. There were no differences between France and the 210 
UK in attitudes and perceived behavioural control regarding self-management support, while subjective 211 
norms were more favourable in the UK (Table 2). 212 
 213 
INSERT Table 2 ABOUT HERE 214 
 215 
Amount of asthma care delivered 216 
The percentages of French and UK HCPs reporting delivering individual medical care and self-217 
management support activities, and the mean (SD) amount of care delivered per country, are presented 218 
  
in Tables 3 and 4. There were significant differences between France and the UK on 2 medical care and 219 
10 self-management support activities. The items that stand out are the much higher rates of allergy 220 
testing in France, and the much higher rates of using validated asthma control questionnaires in the UK.  221 
 Of all HCPs, 5.8% delivered all medical care activities, and 8.3% all self-management support 222 
activities On average, 27.4 of the 37 asthma care activities (74,2%) were delivered routinely, and only 223 
1.8% HCPs delivered all activities. The amount of care was similar in both countries for medical care 224 
(t(239.29)=1.38, p=.17), while asthma self-management support scores were higher in the UK 225 
(t(250.3)=4.85, p<.001). Note that ‘I don’t know’ responses (recoded to ‘No’ for analysis) were only given 226 
in only 1.4% of the answers. 227 
 228 
INSERT Table 3 ABOUT HERE 229 
 230 
INSERT Table 4 ABOUT HERE 231 
 232 
Consistency of asthma care at country level 233 
Medical care 234 
Ten activities could be included in the Mokken scaling analysis (two items endorsed by >95% were 235 
removed). In France, activities were unrelated (scale H(SE)=.13(.03), item H(SE)=.04 (.05) -.19 (.14)). In 236 
the UK, 5 of 10 medical care activities formed a unidimensional scale (scale H(SE)=.55(.08), item H(SE)= 237 
.43 (.15) -.84 (.10), α = .62 [95% CI=.47-.78]) showing latent monotonicity and invariant item ordering. 238 
Hence, French HCPs were likely to deliver different combinations of medical care activities (even when 239 
delivering the same amount of care), while in the UK half of the activities constituted a shared or 240 
consistent approach. 241 
Self-management support 242 
In France, 2 of 25 activities endorsed by >95% of respondents were excluded; the remaining 23 items 243 
showed low homogeneity (scale H(SE)= .23(.03), item H(SE)= .08(.05) -.35(.07)). Exploratory aisp 244 
suggested a 9-item homogenous scale demonstrating latent monotonicity and invariant item ordering. In 245 
the UK, out of the 20 items endorsed by <95%, 17 formed a unidimensional scale (H(SE)= .41(.05), item 246 
  
H= .30(.09) -.57(.09)) showing latent monotonicity and invariant item ordering. Hence, in France 11 of 25 247 
activities, while in the UK 22 of 25 activities formed coherent approaches. Aisp analyses are detailed in 248 
Tables E3-E6 in the Online Repository. 249 
 250 
Consistency of care at HCP level: Number of Guttman errors 251 
When comparing individual HCP responses to response patterns common to the whole sample, the 252 
consistency of care was similar in both countries for medical care (t(229.65)=1.938, p=.05; mean=3.87 253 
and 4.70 in France and the UK), while self-management support was less consistent in France 254 
(t(246.9)=3.056, p=.003; mean=20.55 and 15.53 in France and the UK). 255 
 256 
Associations between the amount and consistency of care 257 
HCPs wo delivered more medical care also delivered more self-management support (r=.54; p<.001). 258 
Moreover, HCPs who delivered medical care that was more consistent with that of other HCPs, also 259 
delivered self-management support that was more consistent with their peers (r=.18; p=.003). Finally, 260 
HCPs who delivered more medical care and self-management support, delivered this care more 261 
consistently (r=.58 and .57 respectively; p<.001). Hence, scores for both components of care and of 262 
quality of care converged: care delivery is much more variable between different HCPs who are already 263 
delivering less of the guideline-recommened care (and vice versa). 264 
   265 
Multivariate analyses explaining asthma care delivery 266 
Medical care 267 
In Model 1, country did not explain the amount of medical care (Table 5). Model 2 revealed that both UK 268 
nurses and French GPs delivered more medical care than the UK GPs. Model 3 showed that HCPs 269 
trained in asthma care during their university studies delivered more guideline-compatible medical care. 270 
French GPs delivered more consistent medical care (Table 5, Model 1), but this effect became non-271 
significant when practice and individual characteristics were added in Models 2 and 3. No significant 272 
effects on consistency of medical care were identified. 273 
 274 
  
INSERT Table 5 ABOUT HERE 275 
 276 
Self-management support 277 
Country did predict the amount of self-management support, with French GPs providing less support than 278 
UK HCPs (Table 6). Model 2 suggested that this effect was explained by the availability of nurses in the 279 
UK. In Model 3 asthma-specific training (ongoing professional development), patient education training 280 
(university studies), subjective norms (‘do others expect me to deliver this?’), and perceived behavioural 281 
control (‘am I able to deliver this?’) explained the amount of self-management support provided. 282 
 UK HCPs delivered more consistent self-management support than French GPs (Table 6, Model 1). 283 
This effect seemed entirely explained by the presence of nurses in the UK (Model 2). In Model 3, 284 
subjective norms also explained consistency of self-management support. 285 
 Model diagnostics revealed one influential case in 3 of the models, but removal did not influence the 286 
results reported here. Given the finding that nurses play such an important role in asthma care delivery in 287 
the UK, Table E7 in the Online Repository provides the descriptives for UK GPs and Nurses separately. 288 
 289 
INSERT Table 6 ABOUT HERE 290 
 291 
DISCUSSION 292 
Using carefully developed tools, advanced psychometric methods, and data from two countries, this study 293 
is – to our knowledge – the first to examine and demonstrate that the amount and consistency of asthma 294 
care provided in France and the UK are highly variable. Importantly, the consistency in the care delivered 295 
was low especially for medical care and amongst HCPs already delivering fewer of the guideline-296 
recommended asthma care activities. We were also able to identify country, system, and individual HCP 297 
differences explaining variability in asthma care in multivariate models. The hypothesis that country 298 
predicts the amount and consistency of care, was only confirmed for self-management support. Another 299 
key finding was that UK nurses tended to deliver more asthma care and in a more consistent manner, 300 
than GPs (also illustrated in Figures 1 and 2); but our analysis did not provide an explanation for that. 301 
Finally, HCPs degree of training in medical care and patient education, and more positive subjective 302 
  
norms (i.e., ‘do others expect me to deliver this?’) and perceptions of control (i.e., ‘am I able to deliver 303 
this?’), explained variability in asthma care. Hence, recommendations for policy and practice would be to 304 
involve practice nurses in French primary care, making patient expectations and best practice examples 305 
visible to HCPs (subjective norms), and expanding HCP training both in asthma and patient education to 306 
enhance knowledge, skills and confidence (perceived behavioural control) in delivering high-quality 307 
asthma care. 308 
 309 
INSERT Figure 1 ABOUT HERE 310 
 311 
INSERT Figure 2 ABOUT HERE 312 
 313 
HCPs were on average able to deliver 75% of the activities recommended in guidelines, but only 314 
1.8% was able to deliver all. This may reflect previously-reported difficulties in applying guidelines in 315 
routine practice (16). Regarding the consistency of care, we could not find any other quality of care 316 
studies that examined this characteristic of care delivery; yet a shared approach to care between different 317 
HCPs reflects the success of guideline implementation and could be a valuable indicator for guideline 318 
developers.The consistency analyses we developed in this study revealed considerable differences 319 
between the theoretical structure of asthma care (what should be delivered) and its real structure (how 320 
HCPs deliver care). In practice, this means patients are likely to receive different care if they would visit 321 
different HCPs, even if these provide exactly the same amount of care. Hence, it could be useful for 322 
future quality of care research to include measures of both the amount and consistency of care. Our 323 
findings also suggest that interventions to improve the quality of care likely require changes at the policy, 324 
management, and HCP level. Therefore, future studies on the quality of asthma care should explore 325 
system, practice, and individual HCP level determinants of asthma care. 326 
This study has several strengths and limitations. It utilised a carefully-designed, comprehensive 327 
questionnaire to assess both medical care and self-management support in two countries. Other studies 328 
on quality of asthma care provided an excellent starting point for this study, but typically focused on a 329 
narrower selection of guideline components (9,10,13–16). Moreover, we used these data to examine the 330 
  
amount and consistency of care provided, which to our knowledge is a novel approach relevant to 331 
evaluating quality of care in a population of HCPs. Finally, we examined what factors amenable to 332 
intervention explain both the amount and consistency of care, identifying avenues for improving both 333 
components. Collecting data in two countries also allowed for cross-country comparisons. A possible 334 
limitation is that socially desirable responses may have led to an overestimation of the care delivered. On 335 
the other hand, recall difficulties could have led to an underestimation of care provided, since the 336 
response option ‘I don’t know’ [whether I routinely deliver this care to my asthma patients] was recoded to 337 
‘No’ (although only 1.4% of the responses was ‘I don’t know’). With only 1.8% reporting delivering all 338 
activities, ceiling effects were not observed. Moreover, the strong correlation between the amount and 339 
consistency of care can be interpreted as evidence of convergent validity, and the significant variance in 340 
the amount and consistency of care predicted by other variables also suggests a valid assessment. 341 
Second, the determinants investigated in this study explained a limited amount of variance, particularly in 342 
medical care. Further work could explore what other system, practice, and individual level determinants 343 
are relevant here. Third, although the participating HCPs formed a sufficiently large and heterogeneous 344 
sample for the analyses conducted, they might not be fully representative of UK and French primary care 345 
professionals. Fourth, this study was embedded in a larger cohort study on the safety and effectiveness 346 
of LABAs. The sample size of this study was not defined a-priori, but determined by the number of 347 
practices in this cohort and the response rates of the participating practices. 348 
 349 
CONCLUSION 350 
In this study we developed a new questionnaire to capture asthma medical care and self-351 
management support, which showed good psychometric properties. IRT analyses allowed us to examine 352 
both the amount and consistency of asthma care – two relevant but conceptually different quality of care 353 
dimensions. Our findings suggest that changes in resources (i.e., involving nurse practitioners in asthma 354 
care delivery), more asthma-specific and patient education training for HCPs, and providing normative 355 
feedback to individual HCPs could enhance the quality of asthma care in the UK and France. This needs 356 
to be corroborated in a future intervention trial. 357 
 358 
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Figure captions 495 
 496 
Figure 1. The association between (a) the consistency and (b) the amount of Self-management 497 
support (y-axis) and Medical care (x-axis). Higher scores on Guttman errors reflect lower 498 
consistency of care. Higher scores on number of activities performed reflect a higher amount of 499 
care provided. Different symbols are used for the different HCPs and the lines reflect 95% 500 
confidence intervals per HCP. HCPs reporting more consistent Self-management support also 501 
report delivering more consistent Medical care; and the same holds for amount of care provided.  502 
 503 
_______ 504 
Figure 1 provided in separate file 505 
_______ 506 
 507 
Figure 2. The association between the amount (y-axis) and consistency (x-axis) of (a) Self-508 
management support and (b) Medical care. Different symbols are used for the different HCPs and 509 
the lines reflect 95% confidence intervals per HCP. The negative associations suggest that HCPs 510 
delivering a higher number of guideline-based care activities also provide more consistent care 511 
(lower scores on Guttman errors). Nurses report delivering more and more consistent medical 512 
care and self-management support than GPs. 513 
 514 
_______ 515 
Figure 2 provided in separate file 516 
  
_______ 517 
 518 
 519 
520 
  
 521 
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Table 1. Psychosocial determinants of self-management support 523 
Determinant Example content No. items 
Cronbach’s 
α 
M (SD) t-test 
(df) p-value France UK 
Attitude 
“I think that, overall, self-
management support is: totally 
my responsibility … not at all my 
responsibility” 
8 .85 5.41 (0.84) 
5.55 
(0.88) 
1.329 
(250.64) .185 
Subjective 
norms 
“Most of my patients expect me 
to provide self-management 
support: strongly agree … 
strongly disagree” 
6 .87 4.71 (1.01) 
5.4 
(1.18) 
5.096 
(233.53) <.001 
Perceived 
behavioural 
control 
“I am confident that I can provide 
self-management support when I 
have limited time with the 
patient: strongly agree … 
strongly disagree” 
10 .93 4.15 (1.1) 
4.55 
(1.42) 
2.533 
(217.61) .012 
  524 
  
Table 2. Sample characteristics - descriptive statistics 525 
Characteristic France (n=156) UK (n=120) p-value 
Gender (women) 53 (33.97%) 71 (59.2%) <0.001 
Use of guidelines (yes) 103 (66.0%) 118 (98.3%) <0.001 
Age 
Less than 30 years 0 (0%) 3 (2.5%) 
0.088 
30 to 39 years 26 (16.67%) 26 (21.7%) 
40 to 49 years 42 (26.92%) 39 (32.5%) 
50 to 59 years 73 (46.79%) 45 (37.5%) 
60 years and over 15 (9.62%) 7 (5.8%) 
Years of experience in asthma care 
Less than 5 years 10 (6.41%) 15 (12.5%) 
0.044 
5 to 9 years 21 (13.46%) 20 (16.7%) 
10 to 19 years 45 (28.85%) 42 (35.0%) 
20 to 29 years 55 (35.26%) 35 (29.2%) 
30 years and over 25 (16.03%) 8 (6.7%) 
Asthma-specific training 
During university studies 110 (70.5%) 106 (88.3%) <0.001 
Ongoing professional development (e.g., 
workshops or conferences) 94 (60.3%) 98 (81.7%) <0.001 
Patient education training 
During university studies 58 (37.2%) 91 (75.8%) <0.001 
Ongoing professional development (e.g., 
workshops or conferences) 115 (73.7%) 89 (74.2%) 1 
Note: group comparisons performed with Fisher’s exact test for binary, Wilcoxon rank-sum test for ordinal, 526 
and t-tests for continuous variables.  527 
 528 
529 
  
Table 3. Frequencies of reporting medical care activities and significance tests for between-530 
country differences (ordered from most to least frequent in France) 531 
Medical care activity Number (%) HCPs 
reporting routine 
delivery 
P-
value 
P-value 
(Holm) 
France 
(n=156)   
UK 
(n=120) 
Assess smoking status for patients over 13 years old 154 (98.72%) 
118 
(98.33%) 1.000 1.000 
Step-up treatment if patients have poor asthma control 152 (97.44%) 
119 
(99.17%) .392 1.000 
Question patients to identify asthma triggers  148 (94.87%) 
107 
(89.17%) .108 .972 
Refer to an asthma specialist if poor asthma control 144 (92.31%) 
99 
(82.50%) .015 .150 
Perform or refer to repeated lung function tests - over 8 
years old  
136 
(87.18%) 
102 
(85.00%) .603 1.000 
Discuss how to avoid or manage triggers  120 (76.92%) 
102 
(85.00%) .125 .972 
Perform or refer to allergy testing  118 (75.64%) 
12 
(10.00%) <.001 <.001 
Assess comorbid conditions and prescribe treatment if 
needed  
118 
(75.64%) 
81 
(67.50%) .139 .972 
Delay stepping-up treatment when poor adherence or 
inhaler use  
116 
(74.36%) 
98 
(81.67%) .190 .972 
Assess smoking status of co-inhabitants (parents, 
partner, roommate)  
115 
(73.72%) 
77 
(64.17%) .113 .972 
Ask patients whether they have been able to manage 
triggers 
95 
(60.90%) 
69 
(57.50%) .621 1.000 
Use a validated set of questions to assess symptoms 30 (19.23%) 
93 
(77.50%) <.001 <.001 
Mean (SD) 9.27 
(1.63) 
8.97(1.84) .17  
Number of HCPs delivering all activities 10 (6.4%) 6 (5%)   
Note: group comparisons via Fisher’s exact test with unadjusted and Holm-adjusted p-values 532 
533 
  
Table 4. Frequencies of reporting adherence support activities and significance tests for 534 
differences 535 
Adherence support activity Number (%) HCPs 
reporting routine 
delivery 
P-
value 
P-
value 
(Holm) 
France 
(n=156)   
UK(n=120)   
Explain the difference between preventer and reliever 
medication 
154 
(98.72%) 
119 
(99.17%) 1.000 1.000 
Discuss what to do in case of worsening symptoms or an 
asthma attack 
150 
(96.15%) 
118 
(98.33%) 0.472 1.000 
Discuss the importance of taking the inhaler medication as 
prescribed for achieving asthma control 
146 
(93.59%) 
118 
(98.33%) 0.074 0.740 
Explain what their medication does to control asthma 145 (92.95%) 
119 
(99.17%) 0.015 0.168 
Ask patients if they have any concerns about using their 
inhaler medication as prescribed  
140 
(89.74%) 
92 
(76.67%) 0.004 0.060 
If patients report adherence difficulties, discuss what can 
be done to overcome these  
139 
(89.10%) 
113 
(94.17%) 0.196 1.000 
Ask patients whether they have always taken their inhaler 
medication as prescribed since their last visit  
133 
(85.26%) 
105 
(87.50%) 0.725 1.000 
Explain what happens to the lungs during an asthma attack  126 (80.77%) 
99 
(82.50%) 0.756 1.000 
Discuss the risks of not taking inhaler medication regularly 
or stopping treatment  
123 
(78.85%) 
108 
(90.00%) 0.014 0.168 
Plan storing spare asthma inhalers at strategic places 
(office, car, school) 
123 
(78.85%) 
75 
(62.50%) 0.003 0.048 
Ask patients with poor asthma control to come more 
frequently to the clinic 
123 
(78.85%) 
116 
(96.67%) <0.001 <0.001 
Discuss with patients which inhaler device they prefer to 
use  
115 
(73.72%) 
83 
(69.17%) 0.421 1.000 
Inquire about side-effects and discuss how these can be 
managed if present  
115 
(73.72%) 
86 
(71.67%) 0.785 1.000 
Encourage patients who you perceive as having good 
adherence  
112 
(71.79%) 
107 
(89.17%) <0.001 <0.001 
Ask patients to show how they use their inhaler 111 (71.15%) 
104 
(86.67%) 0.002 0.034 
Explain common side-effects and how to deal with them  100 (64.10%) 
103 
(85.83%) <0.001 <0.001 
Practice how to use inhalers  99 (63.46%) 
101 
(84.17%) <0.001 <0.001 
Explain the difference between asthmatic and normal 91 99 <0.001 <0.001 
  
airways  (58.33%) (82.50%) 
Ask patients how confident they feel in their ability to take 
the inhaler medication as advised  
87 
(55.77%) 
75 
(62.50%) 0.270 1.000 
Discuss common barriers to taking inhaler medication as 
prescribed (adherence), and how to deal with these  
83 
(53.21%) 
69 
(57.50%) 0.542 1.000 
Together with the patients discuss an individualized plan of 
where, when and how to take their medication  
82 
(52.56%) 
91 
(75.83%) <0.001 <0.001 
Discuss with patients how they can monitor their asthma 
control using symptom diaries or a peak flow meter 
61 
(39.10%) 
97 
(80.83%) <0.001 <0.001 
Ask patients to identify daily routines (e.g. brushing teeth) 
to remember to use inhaler medication at these times  
50 
(32.05%) 
74 
(61.67%) <0.001 <0.001 
Develop with patients a written action plan detailing 
medication intake instructions that they can follow at home  
44 
(28.21%) 
52 
(43.33%) 0.011 0.143 
Encourage patients to use reminders (e.g. an alarm) to 
remember their inhaler medication use  
32 
(20.51%) 
43 
(35.83%) 0.006 0.084 
Mean (SD) 17.21 
(4.16) 
19.72 
(4.34) 
<.001  
Number of HCPs delivering all activities 5 (3.2%) 18 (15%)   
Note: group comparisons via Fisher’s exact test with unadjusted and Holm-adjusted p-values 536 
537 
  
Table 5. Hierarchical regression analyses for the amount and consistency of medical care 538 
(unstandardized estimates and standard errors) 539 
  
 Amount Consistency  
 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Intercept 8.975*** 
(0.157) 
8.249*** 
(0.488) 
6.681*** 
(0.661) 
11.300*** 
(0.323) 
11.191*** 
(1.015) 
9.399*** 
(1.401)         
Country (FR) 0.294 0.719 0.975* 0.854* -0.016 -0.244 
 (0.209) (0.381) (0.400) (0.430) (0.792) (0.848)        
Specialty (nurse)  1.188** 1.030*  1.022 0.156 
  (0.371) (0.432)  (0.772) (0.915)        
Caseload (high)  0.243 0.306  -0.450 -0.304 
  (0.233) (0.235)  (0.486) (0.497)        
Frequency consultations  -0.021 -0.008  -0.116 -0.118 
  (0.030) (0.030)  (0.063) (0.064)        
Minutes consultation  0.016 0.008  0.088 0.077 
  (0.027) (0.028)  (0.057) (0.059)        
Gender (female)   0.053   0.687 
   (0.249)   (0.527)        
Age (groups)   0.308   0.727 
   (0.188)   (0.398)        
Years experience   -0.138   -0.194 
   (0.159)   (0.337)        
Asthma in University studies   0.869***   0.343 
   (0.253)   (0.536)        
Asthma ongoing professional 
development 
  0.213   -0.301 
   (0.242)   (0.513)        
R2 0.007 0.074 0.126 0.014 0.056 0.076 
Adjusted R2 0.004 0.057 0.093 0.011 0.039 0.041  
*p<.05, **p<.01, ***p<.001. Note: More Guttman errors reflect less consistent care; this variable was 540 
reversed here to reflect consistency (rather than inconsistency). 541 
542 
  
Table 6. Hierarchical regression analyses for the amount and consistency of self-management 543 
support (unstandardized estimates and standard errors) 544 
 Amount Consistency 
 Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
Intercept 19.717*** 16.377*** 4.933* 53.467*** 48.878*** 27.143*** 
 (0.387) (1.137) (1.977) (1.222) (3.781) (7.054)        
Country (FR) -2.512*** -0.743 0.906 -5.012** 0.492 1.961 
 (0.515) (0.888) (0.901) (1.625) (2.952) (3.215)        
Specialty (nurse)  4.395*** 4.124***  10.717*** 9.746** 
  (0.866) (0.980)  (2.877) (3.498)        
Caseload(high)  0.788 0.601  2.188 1.763 
  (0.544) (0.505)  (1.809) (1.801)        
Frequency consultations 
 -0.026 0.041  -0.085 0.021 
 (0.070) (0.065)  (0.234) (0.231)        
Minutes consultation  0.075 0.062  -0.080 -0.045 
  (0.064) (0.060)  (0.213) (0.214)        
Gender(female)   -0.826   -1.679 
   (0.535)   (1.907)        
Age (groups)   0.194   0.439 
   (0.404)   (1.442)        
Years experience   -0.089   0.965 
   (0.341)   (1.219)        
Asthma in University 
studies 
  0.703   -0.288 
  (0.564)   (2.013)        
Asthma ongoing 
professional 
development 
  0.803   -2.528 
  (0.534)   (1.905) 
       
Communication 
undergrad or postgrad 
training 
  1.228*   2.052 
  (0.519)   (1.852) 
       
Communication ongoing 
professional 
development 
  1.042*   2.734 
  (0.526)   (1.878) 
       
Attitudes   0.183   -0.642 
   (0.356)   (1.270)        
Subjective norms   0.937**   2.664** 
   (0.282)   (1.005)        
Perceived behavioral 
control 
  0.504*   1.227 
  (0.218)   (0.777)        
R2 0.080 0.227 0.400 0.034 0.100 0.191 
  
Adjusted R2 0.077 0.213 0.365 0.030 0.083 0.144 
*p<.05, **p<.01, ***p<.001. Note: More Guttman errors reflect less consistent care; this variable was 545 
reversed here to reflect consistency (rather than inconsistency) 546 
 547 
